Nuvation Bio Inc. (NUVB) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin -198.31%.
- 2026-03-31: Pre-Tax Margin 6.48%.
- 2025-12-31: Pre-Tax Margin -87.40%.
- 2025-09-30: Pre-Tax Margin -425.24%.
Complete source-backed pre-tax margin history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | -198.31% |
| 2026-03-31 | 6.48% |
| 2025-12-31 | -87.40% |
| 2025-09-30 | -425.24% |
| 2025-06-30 | -1220.92% |
| 2025-03-31 | -1726.20% |
| 2024-12-31 | -865.79% |
| 2024-09-30 | -5668.50% |
| 2024-06-30 | -32229.41% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -325.31% |
| 2024-12-31 | -7213.76% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |